InformationInformation Center

11 2018-09
Notice on Lushan Plasma Collection Station Obtaining Plasma Collection License

Notice on Lushan Plasma Collection Station Obtaining Plasma Collection License

Lushan Plasma Collection Station of Hualan Bio officially starts to collect plasma and provide raw material for blood products. With this material source, the stability of raw material supply will be strongly ensured. It’s beneficial for both increase of production capacity and promotion of product supply.

24 2018-07
R&D Process of Monoclonal Antibody of Hualan Bio

R&D Process of Monoclonal Antibody of Hualan Bio

Hualan Genetic Engineering Co., Ltd. received the acceptance notice of the new drug clinical application for "Recombinant Anti-EGFR All-Human Monoclonal Antibody Injection" issued by the CFDA.